Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada.
Established dividend payer and fair value.
Share Price & News
How has Patterson Companies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PDCO's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PDCO underperformed the US Healthcare industry which returned 18% over the past year.
Return vs Market: PDCO underperformed the US Market which returned 8.9% over the past year.
Price Volatility Vs. Market
How volatile is Patterson Companies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StWhat Is Patterson Companies's (NASDAQ:PDCO) P/E Ratio After Its Share Price Tanked?
2 months ago | Simply Wall StSome Patterson Companies (NASDAQ:PDCO) Shareholders Have Copped A Big 59% Share Price Drop
3 months ago | Simply Wall StWhy Patterson Companies, Inc. (NASDAQ:PDCO) Could Be Worth Watching
Is Patterson Companies undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PDCO ($21.06) is trading below our estimate of fair value ($63.41)
Significantly Below Fair Value: PDCO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PDCO is poor value based on its PE Ratio (41x) compared to the Healthcare industry average (23.5x).
PE vs Market: PDCO is poor value based on its PE Ratio (41x) compared to the US market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: PDCO is poor value based on its PEG Ratio (1.4x)
Price to Book Ratio
PB vs Industry: PDCO is good value based on its PB Ratio (1.4x) compared to the US Healthcare industry average (2.8x).
How is Patterson Companies forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PDCO's forecast earnings growth (30.3% per year) is above the savings rate (2.2%).
Earnings vs Market: PDCO's earnings (30.3% per year) are forecast to grow faster than the US market (22.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PDCO's revenue (3.1% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: PDCO's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PDCO's Return on Equity is forecast to be low in 3 years time (8.3%).
How has Patterson Companies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PDCO has high quality earnings.
Growing Profit Margin: PDCO's current net profit margins (0.9%) are lower than last year (1.4%).
Past Earnings Growth Analysis
Earnings Trend: PDCO's earnings have declined by -13.8% per year over the past 5 years.
Accelerating Growth: PDCO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PDCO had negative earnings growth (-37.8%) over the past year, making it difficult to compare to the Healthcare industry average (10.9%).
Return on Equity
High ROE: PDCO's Return on Equity (3.2%) is considered low.
How is Patterson Companies's financial position?
Financial Position Analysis
Short Term Liabilities: PDCO's short term assets ($1.7B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: PDCO's short term assets ($1.7B) exceed its long term liabilities ($840.1M).
Debt to Equity History and Analysis
Debt Level: PDCO's debt to equity ratio (46.9%) is considered high.
Reducing Debt: PDCO's debt to equity ratio has reduced from 49.9% to 46.9% over the past 5 years.
Debt Coverage: PDCO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: PDCO's interest payments on its debt are not well covered by EBIT (2.5x coverage).
What is Patterson Companies's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PDCO's dividend (4.94%) is higher than the bottom 25% of dividend payers in the US market (1.62%).
High Dividend: PDCO's dividend (4.94%) is in the top 25% of dividend payers in the US market (4.32%)
Stability and Growth of Payments
Stable Dividend: PDCO's dividends per share have been stable in the past 10 years.
Growing Dividend: PDCO's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (202.7%), PDCO's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PDCO's dividends in 3 years are forecast to be covered by earnings (63.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mark Walchirk (53yo)
Mr. Mark S. Walchirk has been the Chief Executive Officer and President of Patterson Companies, Inc. since November 20, 2017. Mr. Walchirk served as the President of U.S. Pharmaceutical at McKesson Corpora ...
CEO Compensation Analysis
Compensation vs Market: Mark's total compensation ($USD4.41M) is about average for companies of similar size in the US market ($USD4.72M).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
|CEO, President & Director||2.58yrs||US$4.41m||0.12% $2.3m|
|CFO & Treasurer||2yrs||US$2.74m||0.034% $673.4k|
|VP, General Counsel & Secretary||4.92yrs||US$2.44m||0.035% $698.8k|
|Chief Human Resources Officer||2.08yrs||US$1.07m||0.0070% $138.3k|
|President of Animal Health International||2.92yrs||US$2.14m||0.034% $680.7k|
|Corporate Controller||2yrs||US$476.40k||0.011% $220.2k|
|Chief Information Officer||3.58yrs||no data||no data|
|Vice President of Investor Relations||4.58yrs||no data||no data|
|Chief Marketing & Digital Officer||3.83yrs||no data||no data|
|Chief Innovation Officer||4yrs||US$970.71k||no data|
Experienced Management: PDCO's management team is considered experienced (3.3 years average tenure).
|CEO, President & Director||2.58yrs||US$4.41m||0.12% $2.3m|
|Independent Director||16.5yrs||US$231.01k||0.060% $1.2m|
|Independent Director||8.75yrs||US$241.01k||0.029% $586.1k|
|Independent Non-Executive Chairman of the Board||3yrs||US$326.01k||0.069% $1.4m|
|Independent Director||2yrs||US$206.01k||0.012% $229.0k|
|Independent Director||6.25yrs||US$231.01k||0.023% $451.0k|
|Independent Director||2.25yrs||US$223.51k||0.012% $229.0k|
|Independent Director||3.08yrs||US$223.51k||0.015% $293.4k|
Experienced Board: PDCO's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Patterson Companies, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Patterson Companies, Inc.
- Ticker: PDCO
- Exchange: NasdaqGS
- Founded: 1877
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$1.988b
- Shares outstanding: 94.38m
- Website: https://www.pattersoncompanies.com
Number of Employees
- Patterson Companies, Inc.
- 1031 Mendota Heights Road
- St. Paul
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PDCO||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Oct 1992|
|PD2||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Oct 1992|
|0KGB||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Oct 1992|
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The Dental segment offers consumable products, including infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; technology solutions, such as practice management software and e-commerce solutions; patient education systems; and office forms and stationery. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing services. The Animal Health segment distributes pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. It also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The company serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul, Minnesota.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/06 02:54|
|End of Day Share Price||2020/06/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.